Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Kiyan Heshmat-Ghahdarijani, Roya Modaresi, Sobhan Pourmasjedi, Setayesh Sotoudehnia Korani, Ali Rezazadeh Roudkoli, Razieh Ziaei, Armita Farid, Mehrnaz Salehi, Afshin Heidari & Sina Neshat. (2023) Reducing Cardiac Steatosis: Interventions to Improve Diastolic Function: A Narrative Review. Current Problems in Cardiology 48:8, pages 101739.
Crossref
Crossref
Yue Gao, Jiaxin Zeng, Fengwei Zou, Xinwei Zhang, Zhiyong Qian, Yao Wang, Xiaofeng Hou & Jiangang Zou. (2023) Causal effect of central obesity on left ventricular structure and function in preserved EF population: A Mendelian randomization study. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Abdulrahman Ismaiel & Dan L. Dumitrascu. (2023) How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver Disease. American Journal of Therapeutics 30:3, pages e242-e256.
Crossref
Crossref
Nicholas W.S. Chew, Mark D. Muthiah & Arun J. Sanyal. 2023. Cardiovascular Endocrinology and Metabolism. Cardiovascular Endocrinology and Metabolism
137
173
.
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka & Dina Halegoua-DeMarzio. (2022) Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 9:12, pages 419.
Crossref
Crossref
C. Partington, H. Hodgkiss-Geere, G. R. T. Woods, J. Dukes-McEwan, J. Flanagan, V. Biourge & A. J. German. (2022) The effect of obesity and subsequent weight reduction on cardiac structure and function in dogs. BMC Veterinary Research 18:1.
Crossref
Crossref
Nicholas W. S. Chew, Cheng Han Ng, Mark Dhinesh Muthiah & Arun J. Sanyal. (2022) Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. Current Atherosclerosis Reports 24:7, pages 515-532.
Crossref
Crossref
Viktoriia V. Yevsieieva, Ivan M. Todurov, Olexandr V. Perekhrestenko & Sergiy V. Kosiukhno. (2022) IMPLEMENTATION OF ENHANCED RECOVERY AFTER SURGERY PROTOCOL FOR METABOLIC SURGERY PATIENTS (LITERATURE REVIEW). Wiadomości Lekarskie 75:4, pages 1031-1038.
Crossref
Crossref
Nicolas L. Madsen, Jessica E. Haley, Ryan A. Moore, Philip R. Khoury & Elaine M. Urbina. (2021) Increased Arterial Stiffness Is Associated With Reduced Diastolic Function in Youth With Obesity and Type 2 Diabetes. Frontiers in Pediatrics 9.
Crossref
Crossref
Jun Ren, Ne N. Wu, Shuyi Wang, James R. Sowers & Yingmei Zhang. (2021) Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiological Reviews 101:4, pages 1745-1807.
Crossref
Crossref
Elisenda Climent, Anna Oliveras, Juan Pedro-Botet, Albert Goday & David Benaiges. (2021) Bariatric Surgery and Hypertension. Journal of Clinical Medicine 10:18, pages 4049.
Crossref
Crossref
Anna Oliveras, Lluís Molina, Albert Goday, Laia Sans, Marta Riera, Susana Vazquez, David Benaiges, Ana Marina Granados, José Manuel Ramon & Julio Pascual. (2020) Effect of bariatric surgery on cardiac structure and function in obese patients: Role of the renin‐angiotensin system. The Journal of Clinical Hypertension 23:1, pages 181-192.
Crossref
Crossref
Partho Sengupta & Christopher Michael Bianco. 2021. Diastology. Diastology
473
488
.
Thida Tabucanon, Jennifer Wilcox & W. H. Wilson Tang. (2020) Does Weight Loss Improve Clinical Outcomes in Overweight and Obese Patients with Heart Failure?. Current Diabetes Reports 20:12.
Crossref
Crossref
Fei Fei Gong, Jennifer M. Coller, Michele McGrady, Umberto Boffa, Louise Shiel, Danny Liew, Simon Stewart, Alice J. Owen, Henry Krum, Christopher M. Reid, David L. Prior & Duncan J. Campbell. (2020) Age‐related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk. ESC Heart Failure 7:3, pages 1344-1361.
Crossref
Crossref
Milton Packer. (2019) Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction. Journal of Cardiac Failure 25:12, pages 986-1003.
Crossref
Crossref
Duncan J Campbell, Fei Fei Gong, Michael V Jelinek, Julian M Castro, Jennifer M Coller, Michele McGrady, Umberto Boffa, Louise Shiel, Danny Liew, Simon Stewart, Alice J Owen, Henry Krum, Christopher M Reid & David L Prior. (2019) Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction. European Journal of Preventive Cardiology 26:15, pages 1594-1602.
Crossref
Crossref
Abdulrahman Ismaiel & Dan L. Dumitraşcu. (2019) Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review. Frontiers in Medicine 6.
Crossref
Crossref
Hale Tuhan, Tülay Demircan, Ayca Altıncık, Gönül Çatlı, Özgür Kızılca, Tuğba Egeli, Mustafa Kır, Şule Can, Bumin Dündar, Ece Böber & Ayhan Abacı. (2019) Impaired systolic and diastolic left ventricular function in children and adolescents with congenital adrenal hyperplasia receiving corticosteroid therapy. Cardiology in the Young 29:3, pages 319-324.
Crossref
Crossref
Sukka Santosh Reddy, Heena Agarwal & Manoj Kumar Barthwal. (2018) Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice. Journal of Molecular and Cellular Cardiology 123, pages 46-57.
Crossref
Crossref
Fei Fei Gong, Michael V Jelinek, Julian M Castro, Jennifer M Coller, Michele McGrady, Umberto Boffa, Louise Shiel, Danny Liew, Rory Wolfe, Simon Stewart, Alice J Owen, Henry Krum, Christopher M Reid, David L Prior & Duncan J Campbell. (2018) Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort. Open Heart 5:2, pages e000782.
Crossref
Crossref
Quentin M. Anstee, Alessandro Mantovani, Herbert Tilg & Giovanni Targher. (2018) Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 15:7, pages 425-439.
Crossref
Crossref
Makiko Suto, Hidekazu Tanaka, Yasuhide Mochizuki, Jun Mukai, Hiroki Takada, Fumitaka Soga, Kumiko Dokuni, Yutaka Hatani, Keiko Hatazawa, Hiroki Matsuzoe, Hiroyuki Sano, Hiroyuki Shimoura, Junichi Ooka, Kensuke Matsumoto, Yushi Hirota, Wataru Ogawa & Ken-ichi Hirata. (2017) Impact of overweight on left ventricular function in type 2 diabetes mellitus. Cardiovascular Diabetology 16:1.
Crossref
Crossref
Fei Fei Gong, Duncan J. Campbell & David L. Prior. (2017) Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects. JACC: Cardiovascular Imaging 10:12, pages 1504-1519.
Crossref
Crossref